MAINSTAY MEDICAL HOLDINGS PUBLIC LIMITED COMPANY

Mainstay Medical Holdings Public Limited Company is a medical-technology firm dedicated to transforming the treatment of mechanical chronic low back pain. Its flagship offering, the ReActiv8® Restorative Neurostimulation system, is the world's first and only therapy that directly stimulates the nerves of the lumbar stabilising muscles, aiming to break the cycle of pain, degeneration and loss of function.

The ReActiv8 system delivers a restorative approach rather than merely masking symptoms, providing patients with a non-pharmacological option that can reduce pain scores, improve disability indices and even lessen reliance on opioids. Clinical evidence from the ReActiv8-B trial shows sustained outcomes after three years, with significant reductions in VAS pain scores and ODI disability scores. The therapy is now full-body MRI conditional, expanding its suitability for a broader patient base.

Mainstay Medical supports both patients and physicians with comprehensive information, patient stories, and up-to-date clinical data, positioning the company as a leader in innovative, evidence-based solutions for chronic low back pain.